Inadequate ovarian function suppression and endocrine therapy manipulations in premenopausal patients with early breast cancer on adjuvant LHRH agonist and aromatase inhibitor: a cohort study. [PDF]
Valenza C +14 more
europepmc +1 more source
Therapeutic Fasting as a Novel Approach to Mitigate Musculoskeletal Symptoms in Breast Cancer Patients undergoing Aromatase Inhibitor Therapy: A Feasibility Study Protocol. [PDF]
Meyer H +10 more
europepmc +1 more source
CDK4/6 inhibitor in combination with aromatase inhibitor effective in metastatic hidradenocarcinoma. [PDF]
Glatzel V +6 more
europepmc +1 more source
Real-world progression-free survival 2 (PFS2) and tumor response of CDK4/6 inhibitors plus an aromatase inhibitor in patients with HR+/HER2- metastatic breast cancer in US routine clinical practice. [PDF]
Rugo HS +11 more
europepmc +1 more source
Determination and Disposition of the Aromatase Inhibitor Exemestane in CYP3A-Deficient Mice. [PDF]
Taheri H +4 more
europepmc +1 more source
Real-world effectiveness of palbociclib plus an aromatase inhibitor in HR+/HER2- MBC patients living in disadvantaged neighborhoods. [PDF]
Lynce F +6 more
europepmc +1 more source
Aromatase Inhibitor-Related Lower Limb Tendinopathies: Ultrasound is on the Agenda. [PDF]
Yalçınkaya B +4 more
europepmc +1 more source
The experience of musculoskeletal symptoms among patients with breast cancer during aromatase inhibitor therapy: A qualitative study. [PDF]
Cao Y +6 more
europepmc +1 more source

